CDDF (ASBL)

Active

VAT

BE 0738.523.752

Full name

Cancer Drug Development Forum

Address

Clos Chapelle-aux-Champs 30

1200 Woluwe-Saint-Lambert

Established

22-10-2019

Principal activity

Associations for the prevention of health

Try for free

Crisis resilience of CDDF

Which companies are best armed against current economic trends and the energy crisis?

2023		2022
Profit/Loss	€32,922	-73%	€121,889
Equity	€811,536	4%	€778,614
Gross margin	€298,477	-8%	€325,670
Employees	2,5 FTE	-	-

Publications in the Belgian Official Journal for CDDF

Type	Date	Pdf	Subject
	26-09-2024		Resignations, Appointments (FR)
	22-05-2024		Resignations, Appointments (FR)
	11-08-2023		Resignations, Appointments - Articles of Association (Translation, Coordination, Other Modifications… (FR)
	06-06-2023		Articles of Association (Translation, Coordination, Other Modifications, …) (FR)
	26-09-2022		Resignations, Appointments - Articles of Association (Translation, Coordination, Other Modifications… (FR)

Sources

Frequently asked questions

What is the VAT number of Cancer Drug Development Forum?

The VAT number of Cancer Drug Development Forum is BE0738523752.

When was Cancer Drug Development Forum founded?

Cancer Drug Development Forum was founded on 22-10-2019.

What is the address of Cancer Drug Development Forum?

The current registered office of Cancer Drug Development Forum is located at Clos Chapelle-aux-Champs 30, 1200 Woluwe-Saint-Lambert.

When was the last time Cancer Drug Development Forum filed their annual financial statements?

The most recent financial statements of Cancer Drug Development Forum were filed on 04-12-2024. You can view them here.

How many employees does Cancer Drug Development Forum have?

There are 2,5 FTEs working at Cancer Drug Development Forum according to the staff figures in the most recent financial statements.

What is the annual turnover of Cancer Drug Development Forum?

At the time of its most recent financial statements, Cancer Drug Development Forum did not publish any turnover figures. Cancer Drug Development Forum reported a gross margin of €298,476.72.